Paragon 28 Reports First Quarter 2024 Financial Results and Reaffirms 2024 Net Revenue Guidance
Paragon 28, Inc. (FNA)
Company Research
Source: Business Wire
ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or "Company”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today reported financial results for the quarter ended March 31, 2024, and reaffirmed its 2024 net revenue guidance.First Quarter 2024 Financial ResultsConsolidated net revenue for the first quarter of 2024 was a record $61.1 million, representing 17.4% reported and constant currency growth over the first quarter of 2023. Foreign currency impact on first quarter 2024 reported net revenue growth was not material.U.S. net revenue for the first quarter of 2024 was $51.1 million, representing growth of 13.5% over the first quarter of 2023.International net revenue for the first quarter of 2024 was a record $10.0 million, representing 42.2% and 42.5% reported and constant currency growth, respectively, over the first quarter of 2023.Gross profit margin was 80.0% for the first quarter of 2024 compared t
Show less
Read more
Impact Snapshot
Event Time:
FNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FNA alerts
High impacting Paragon 28, Inc. news events
Weekly update
A roundup of the hottest topics
FNA
News
- Paragon 28, Inc. (NYSE:FNA) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Paragon 28, Inc. (NYSE: FNA) had its price target lowered by analysts at JMP Securities from $23.00 to $20.00. They now have a "market outperform" rating on the stock.MarketBeat
- Paragon 28, Inc. (NYSE: FNA) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $15.00 price target on the stock, down previously from $18.00.MarketBeat
- Paragon 28, Inc. (NYSE: FNA) had its price target lowered by analysts at Needham & Company LLC from $17.00 to $14.00. They now have a "buy" rating on the stock.MarketBeat
- Paragon 28 to Present at the Bank of America Securities 2024 Healthcare ConferenceBusiness Wire
FNA
Sec Filings
- 5/30/24 - Form 144
- 5/28/24 - Form 144
- 5/22/24 - Form 8-K
- FNA's page on the SEC website